Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Gray Matter Pathology in MS: Neuroimaging and Clinical Correlations.
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
T cell-depleted splenocytes from mice pre-immunized with neuroantigen in incomplete Freund's adjuvant involved in protection from experimental autoimmune encephalomyelitis.
PML in a patient with lymphocytopenia treated with dimethyl fumarate.
FAS-ligand regulates differential activation-induced cell death of human T-helper 1 and 17 cells in healthy donors and multiple sclerosis patients.
Effects of peptide fraction and counter ion on the development of clinical signs in experimental autoimmune encephalomyelitis.
IL7Rα Contributes to Experimental Autoimmune Encephalomyelitis through Altered T Cell Responses and Nonhematopoietic Cell Lineages.
Achieving valid patient-reported outcomes measurement: a lesson from fatigue in multiple sclerosis.
Disturbance of respiratory muscle control in a patient with early-stage multiple sclerosis.
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2.
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
Clinical response and tolerability of fampridine in clinical practice.
Dual roles of the adenosine A2a receptor in autoimmune neuroinflammation.
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
Serum NSE and multiple sclerosis.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Atypical presentation of multiple sclerosis.
Remyelination Therapy in Multiple Sclerosis.
The cerebellar channelopathy of multiple sclerosis.
Celastrol Ameliorates EAE Induction by Suppressing Pathogenic T Cell Responses in the Peripheral and Central Nervous Systems.
Epigenetic regulation of polyomavirus JC involves acetylation of specific lysine residues in NF-κB p65.
Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.
Aquaporin-4 antibody isoform binding specificities do not explain clinical variations in NMO.
No sex-specific difference in disease trajectory in multiple sclerosis patients before and after age 50.
Pages
« first
‹ previous
…
600
601
602
603
604
605
606
607
608
…
next ›
last »